PURPOSE: Indocyanine green (ICG) has been widely used as a vital dye for macular surgery. However, ICG can be toxic to retinal cells. Here we evaluate whether tempol (4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl), a free radical scavenger, can protect against ICG-induced retinal damage in rats. METHODS: Brown Norway rats received intravitreal injections of ICG 0.5 % or BSS as controls. Tempol (20 mg/kg BW) or PBS as a control was administered intraperitoneally 24 h and 30 min before ICG and once daily for 7 consecutive days. Tempol was detected in the retina using electron paramagnetic resonance (EPR) spectroscopy. One week after ICG injections, the effects of tempol on retinal toxicity were assessed by retinal ganglion cell (RGC) back-labeling and by light microscopy. Electroretinography (ERG) was performed after 1 and 2 weeks. RESULTS: ICG administration reduced RGC numbers by 17 % (1,943 ± 45 vs. 2,342 ± 31 RGCs/mm(2)). Tempol treatment rescued RGCs in a significant manner (2,258 ± 36, p < 0.01) and diminished morphological changes detected by light microscopy. ICG-injected eyes showed a significant reduction of ERG potentials only in PBS-treated animals (V(max) 530 ± 145 µV vs. 779 ± 179 µV, p = 0.0052), but not in the tempol-treated group. CONCLUSIONS: Tempol significantly attenuates ICG-induced toxicity in rat retinas and may therefore be considered for further evaluation as accompanying treatment in ICG-assisted chromovitrectomy.
PURPOSE:Indocyanine green (ICG) has been widely used as a vital dye for macular surgery. However, ICG can be toxic to retinal cells. Here we evaluate whether tempol (4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl), a free radical scavenger, can protect against ICG-induced retinal damage in rats. METHODS: Brown Norway rats received intravitreal injections of ICG 0.5 % or BSS as controls. Tempol (20 mg/kg BW) or PBS as a control was administered intraperitoneally 24 h and 30 min before ICG and once daily for 7 consecutive days. Tempol was detected in the retina using electron paramagnetic resonance (EPR) spectroscopy. One week after ICG injections, the effects of tempol on retinal toxicity were assessed by retinal ganglion cell (RGC) back-labeling and by light microscopy. Electroretinography (ERG) was performed after 1 and 2 weeks. RESULTS:ICG administration reduced RGC numbers by 17 % (1,943 ± 45 vs. 2,342 ± 31 RGCs/mm(2)). Tempol treatment rescued RGCs in a significant manner (2,258 ± 36, p < 0.01) and diminished morphological changes detected by light microscopy. ICG-injected eyes showed a significant reduction of ERG potentials only in PBS-treated animals (V(max) 530 ± 145 µV vs. 779 ± 179 µV, p = 0.0052), but not in the tempol-treated group. CONCLUSIONS:Tempol significantly attenuates ICG-induced toxicity in rat retinas and may therefore be considered for further evaluation as accompanying treatment in ICG-assisted chromovitrectomy.
Authors: Ayelet M Samuni; Eric Y Chuang; Murali C Krishna; William Stein; William DeGraff; Angelo Russo; James B Mitchell Journal: Proc Natl Acad Sci U S A Date: 2003-04-17 Impact factor: 11.205
Authors: M Remy; S Thaler; R G Schumann; C A May; M Fiedorowicz; F Schuettauf; M Grüterich; S G Priglinger; M M Nentwich; A Kampik; C Haritoglou Journal: Br J Ophthalmol Date: 2008-08 Impact factor: 4.638
Authors: Fernando M Penha; Marianne Pons; Elaine de Paula Fiod Costa; Eduardo B Rodrigues; Mauricio Maia; Maria E Marin-Castaño; Michel Eid Farah Journal: Ophthalmologica Date: 2013-09-06 Impact factor: 3.250
Authors: Kai Januschowski; Sebastian Mueller; Rebecca Dollinger; Sven Schnichels; Johanna Hofmann; Martin S Spitzer; Karl-Ulrich Bartz-Schmidt; Peter Szurman; Sebastian Thaler Journal: Graefes Arch Clin Exp Ophthalmol Date: 2014-05-02 Impact factor: 3.117
Authors: S Thaler; C Haritoglou; F Schuettauf; T Choragiewicz; C A May; F Gekeler; M D Fischer; H Langhals; A Schatz Journal: Eye (Lond) Date: 2014-12-19 Impact factor: 3.775
Authors: Michal Fiedorowicz; Tomasz Choragiewicz; Sebastian Thaler; Frank Schuettauf; Dominika Nowakowska; Kamila Wojtunik; Michele Reibaldi; Teresio Avitabile; Tomasz Kocki; Waldemar A Turski; Agnieszka Kaminska; Pawel Grieb; Eberhart Zrenner; Robert Rejdak; Mario Damiano Toro Journal: Front Physiol Date: 2019-10-01 Impact factor: 4.566